Orchid Pharma share news, announcements and annual reports
NSE: ORCHPHARMABSE: 524372Pharmaceuticals & BiotechnologySmall Cap
Share price at the NSE close on 30 Oct 2026. Previous close ₹893.40.
30 Oct: open ₹893.45, high ₹893.45, low ₹830.00
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹5,009 Cr919th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Earlier quarters restated in the year
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- Shares changed
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 0.2%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.19
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 88,12456.8% delivered
Orchid Pharma share news and announcements
856 announcements, routine notices left out, newest first. Page 7 of 18.
Jul 2021
Jun 2021
30 Jun · Meeting
18 Jun · Related Party Transactions
7 Jun · Corporate action
May 2021
24 May · Results
22 May · Results
22 May · Board meeting
15 May · Board meeting
Apr 2021
Feb 2021
9 Feb · Results
9 Feb · Board meeting
2 Feb · Board meeting
Jan 2021
Dec 2020
31 Dec · Meeting
10 Dec · Related Party Transactions
Nov 2020
11 Nov · Results
11 Nov · Board meeting
Oct 2020
5 Oct · Rating
Sep 2020
7 Sep · Results
7 Sep · Board meeting
1 Sep · Rating
Aug 2020
31 Aug · Board meeting
Jul 2020
30 Jul · Updates
24 Jul · Legal
Exchange has sought clarification from Orchid Pharma Limited for the quarter ended 31-Mar-2020 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Financial results submitted is not as per format prescribed by SEBI The response of the Company is awaited.19 Jul · Updates
Jun 2020
29 Jun · Results
29 Jun · Board meeting
26 Jun · Board meeting
Apr 2020
6 Apr · Management
3 Apr · Corporate Insolvency Resolution Process
2 Apr
File name: “ImplementationofApprovedResolutionPlanMCDecisions”